Evolent Health, Inc. (NYSE: EVH) Stock Competitors & Peer Comparison
See EVH's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EVH and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EVH | $5.74 | +1.15% | 652.4M | 580.00 | $0.01 | N/A |
| VEEV | $195.03 | -1.19% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $62.91 | -4.25% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $73.13 | +7.28% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $241.87 | +5.75% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $48.11 | -10.23% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.40 | +2.45% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $88.29 | +2.68% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
EVH vs VEEV Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while VEEV trades at $195.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas VEEV's P/E ratio is 23.46. In terms of profitability, EVH's ROE is -0.78%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, EVH is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for EVH.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
EVH vs GEHC Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while GEHC trades at $62.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas GEHC's P/E ratio is 13.83. In terms of profitability, EVH's ROE is -0.78%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, EVH is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for EVH.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
EVH vs GEHCV Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas GEHCV's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, EVH is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for EVH.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
EVH vs BTSG Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while BTSG trades at $73.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas BTSG's P/E ratio is 57.01. In terms of profitability, EVH's ROE is -0.78%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, EVH is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for EVH.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
EVH vs BTSGU Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while BTSGU trades at $241.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, EVH's ROE is -0.78%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, EVH is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for EVH.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
EVH vs TEM Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while TEM trades at $48.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas TEM's P/E ratio is -104.94. In terms of profitability, EVH's ROE is -0.78%, compared to TEM's ROE of -0.70%. Regarding short-term risk, EVH is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for EVH.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
EVH vs SGFY Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SGFY's P/E ratio is 70.91. In terms of profitability, EVH's ROE is -0.78%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, EVH is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for EVH.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
EVH vs HQY Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while HQY trades at $97.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas HQY's P/E ratio is 23.06. In terms of profitability, EVH's ROE is -0.78%, compared to HQY's ROE of +0.11%. Regarding short-term risk, EVH is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for EVH.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
EVH vs HNGE Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while HNGE trades at $88.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas HNGE's P/E ratio is 44.66. In terms of profitability, EVH's ROE is -0.78%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, EVH is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for EVH.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
EVH vs RCM Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas RCM's P/E ratio is -102.21. In terms of profitability, EVH's ROE is -0.78%, compared to RCM's ROE of +0.00%. Regarding short-term risk, EVH is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for EVH.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
EVH vs TXG Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while TXG trades at $43.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas TXG's P/E ratio is -257.29. In terms of profitability, EVH's ROE is -0.78%, compared to TXG's ROE of -0.03%. Regarding short-term risk, EVH is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for EVH.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
EVH vs DOCS Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while DOCS trades at $21.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas DOCS's P/E ratio is 14.07. In terms of profitability, EVH's ROE is -0.78%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, EVH is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for EVH.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
EVH vs ONEM Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ONEM's P/E ratio is -7.77. In terms of profitability, EVH's ROE is -0.78%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, EVH is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for EVH.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
EVH vs PRVA Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while PRVA trades at $26.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas PRVA's P/E ratio is 168.13. In terms of profitability, EVH's ROE is -0.78%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, EVH is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for EVH.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
EVH vs PGNY Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while PGNY trades at $32.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas PGNY's P/E ratio is 23.31. In terms of profitability, EVH's ROE is -0.78%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, EVH is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for EVH.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
EVH vs HTFL Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while HTFL trades at $24.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas HTFL's P/E ratio is -12.92. In terms of profitability, EVH's ROE is -0.78%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, EVH is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for EVH.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
EVH vs WGS Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while WGS trades at $61.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas WGS's P/E ratio is 74.68. In terms of profitability, EVH's ROE is -0.78%, compared to WGS's ROE of -0.28%. Regarding short-term risk, EVH is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for EVH.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
EVH vs TDOC Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while TDOC trades at $9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas TDOC's P/E ratio is -10.47. In terms of profitability, EVH's ROE is -0.78%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, EVH is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for EVH.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
EVH vs NXGN Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas NXGN's P/E ratio is -266.00. In terms of profitability, EVH's ROE is -0.78%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, EVH is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for EVH.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
EVH vs OMDA Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while OMDA trades at $23.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas OMDA's P/E ratio is 338.57. In terms of profitability, EVH's ROE is -0.78%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, EVH is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for EVH.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
EVH vs AGTI Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas AGTI's P/E ratio is -71.79. In terms of profitability, EVH's ROE is -0.78%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, EVH is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for EVH.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
EVH vs GDRX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while GDRX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas GDRX's P/E ratio is 9.52. In terms of profitability, EVH's ROE is -0.78%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, EVH is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for EVH.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
EVH vs CERT Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CERT trades at $6.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CERT's P/E ratio is 17.77. In terms of profitability, EVH's ROE is -0.78%, compared to CERT's ROE of -0.01%. Regarding short-term risk, EVH is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
EVH vs CCLDO Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CCLDO's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, EVH is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
EVH vs HSTM Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while HSTM trades at $28.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas HSTM's P/E ratio is 38.08. In terms of profitability, EVH's ROE is -0.78%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, EVH is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for EVH.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
EVH vs WGSWW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, EVH's ROE is -0.78%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, EVH is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for EVH.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
EVH vs PHR Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, PHR has a market cap of 662M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while PHR trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas PHR's P/E ratio is 38.25. In terms of profitability, EVH's ROE is -0.78%, compared to PHR's ROE of +0.03%. Regarding short-term risk, EVH is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for EVH.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
EVH vs MPLN-WT Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, EVH is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for EVH.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
EVH vs ACCD Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ACCD's P/E ratio is -3.08. In terms of profitability, EVH's ROE is -0.78%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, EVH is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for EVH.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
EVH vs SHCR Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SHCR's P/E ratio is -3.76. In terms of profitability, EVH's ROE is -0.78%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, EVH is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for EVH.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
EVH vs CTEV Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CTEV trades at $30.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CTEV's P/E ratio is -2.33. In terms of profitability, EVH's ROE is -0.78%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, EVH is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for EVH.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
EVH vs NRC Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while NRC trades at $21.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas NRC's P/E ratio is 26.56. In terms of profitability, EVH's ROE is -0.78%, compared to NRC's ROE of +0.57%. Regarding short-term risk, EVH is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for EVH.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
EVH vs SOPH Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SOPH trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SOPH's P/E ratio is -11.29. In terms of profitability, EVH's ROE is -0.78%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, EVH is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for EVH.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
EVH vs SLGCW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, EVH's ROE is -0.78%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, EVH is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for EVH.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
EVH vs SLGC Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SLGC's P/E ratio is -3.04. In terms of profitability, EVH's ROE is -0.78%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, EVH is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for EVH.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
EVH vs TBRG Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas TBRG's P/E ratio is 9.37. In terms of profitability, EVH's ROE is -0.78%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, EVH is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for EVH.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
EVH vs MPLN Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MPLN's P/E ratio is -0.23. In terms of profitability, EVH's ROE is -0.78%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, EVH is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for EVH.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
EVH vs SLP Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SLP's P/E ratio is 20.72. In terms of profitability, EVH's ROE is -0.78%, compared to SLP's ROE of +0.06%. Regarding short-term risk, EVH is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for EVH.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
EVH vs TRHC Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas TRHC's P/E ratio is -4.27. In terms of profitability, EVH's ROE is -0.78%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, EVH is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for EVH.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
EVH vs SMFR Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SMFR's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, EVH is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for EVH.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
EVH vs SPOK Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SPOK trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SPOK's P/E ratio is 17.73. In terms of profitability, EVH's ROE is -0.78%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, EVH is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for EVH.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
EVH vs SY Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SY trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SY's P/E ratio is -5.09. In terms of profitability, EVH's ROE is -0.78%, compared to SY's ROE of -0.16%. Regarding short-term risk, EVH is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for EVH.Check SY's competition here
American Well Corporation (NYSE: AMWL)
EVH vs AMWL Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while AMWL trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas AMWL's P/E ratio is -2.54. In terms of profitability, EVH's ROE is -0.78%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, EVH is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for EVH.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
EVH vs HCAT Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while HCAT trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas HCAT's P/E ratio is 11.25. In terms of profitability, EVH's ROE is -0.78%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, EVH is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for EVH.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
EVH vs CPSI Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CPSI's P/E ratio is -183.80. In terms of profitability, EVH's ROE is -0.78%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, EVH is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for EVH.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
EVH vs OPRX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while OPRX trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas OPRX's P/E ratio is 6.14. In terms of profitability, EVH's ROE is -0.78%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, EVH is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for EVH.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
EVH vs AUGX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas AUGX's P/E ratio is -4.99. In terms of profitability, EVH's ROE is -0.78%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, EVH is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for EVH.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
EVH vs CCLD Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CCLD trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CCLD's P/E ratio is 8.59. In terms of profitability, EVH's ROE is -0.78%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, EVH is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
EVH vs DH Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while DH trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas DH's P/E ratio is 2.92. In terms of profitability, EVH's ROE is -0.78%, compared to DH's ROE of -0.67%. Regarding short-term risk, EVH is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for EVH.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
EVH vs FORA Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas FORA's P/E ratio is -24.11. In terms of profitability, EVH's ROE is -0.78%, compared to FORA's ROE of -0.17%. Regarding short-term risk, EVH is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for EVH.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
EVH vs CCLDP Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CCLDP's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, EVH is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
EVH vs ONMD Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ONMD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ONMD's P/E ratio is -4.53. In terms of profitability, EVH's ROE is -0.78%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, EVH is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for EVH.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
EVH vs SNCE Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SNCE's P/E ratio is -0.27. In terms of profitability, EVH's ROE is -0.78%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, EVH is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for EVH.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
EVH vs AKLI Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas AKLI's P/E ratio is -0.71. In terms of profitability, EVH's ROE is -0.78%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, EVH is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for EVH.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
EVH vs SHLT Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SHLT's P/E ratio is -3.87. In terms of profitability, EVH's ROE is -0.78%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, EVH is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for EVH.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
EVH vs SHCRW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, EVH's ROE is -0.78%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, EVH is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for EVH.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
EVH vs ONMDW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ONMDW's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, EVH is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for EVH.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
EVH vs STRM Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas STRM's P/E ratio is -2.40. In terms of profitability, EVH's ROE is -0.78%, compared to STRM's ROE of -0.32%. Regarding short-term risk, EVH is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for EVH.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
EVH vs RNLX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas RNLX's P/E ratio is -0.33. In terms of profitability, EVH's ROE is -0.78%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, EVH is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for EVH.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
EVH vs LIFW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas LIFW's P/E ratio is -0.02. In terms of profitability, EVH's ROE is -0.78%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, EVH is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for EVH.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
EVH vs EUDA Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while EUDA trades at $11.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas EUDA's P/E ratio is -21.32. In terms of profitability, EVH's ROE is -0.78%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, EVH is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for EVH.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
EVH vs BBLN Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas BBLN's P/E ratio is -0.04. In terms of profitability, EVH's ROE is -0.78%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, EVH is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for EVH.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
EVH vs BEATW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas BEATW's P/E ratio is -0.04. In terms of profitability, EVH's ROE is -0.78%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, EVH is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for EVH.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
EVH vs ETAO Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ETAO's P/E ratio is -0.01. In terms of profitability, EVH's ROE is -0.78%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, EVH is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for EVH.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
EVH vs BFRG Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while BFRG trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas BFRG's P/E ratio is -1.20. In terms of profitability, EVH's ROE is -0.78%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, EVH is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for EVH.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
EVH vs HLTH Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas HLTH's P/E ratio is -0.02. In terms of profitability, EVH's ROE is -0.78%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, EVH is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for EVH.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
EVH vs SCNX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas SCNX's P/E ratio is -0.16. In terms of profitability, EVH's ROE is -0.78%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, EVH is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for EVH.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
EVH vs UPH Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas UPH's P/E ratio is -0.07. In terms of profitability, EVH's ROE is -0.78%, compared to UPH's ROE of -1.05%. Regarding short-term risk, EVH is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for EVH.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
EVH vs UPH-WT Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, EVH is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for EVH.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
EVH vs MGRX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MGRX's P/E ratio is -0.31. In terms of profitability, EVH's ROE is -0.78%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, EVH is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for EVH.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
EVH vs PEAR Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas PEAR's P/E ratio is -0.08. In terms of profitability, EVH's ROE is -0.78%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, EVH is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for EVH.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
EVH vs PEARW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas PEARW's P/E ratio is -0.00. In terms of profitability, EVH's ROE is -0.78%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, EVH is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for EVH.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
EVH vs OTRK Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas OTRK's P/E ratio is -0.02. In terms of profitability, EVH's ROE is -0.78%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, EVH is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for EVH.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
EVH vs VSEEW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, EVH's ROE is -0.78%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, EVH is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for EVH.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
EVH vs HCTI Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while HCTI trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas HCTI's P/E ratio is -0.23. In terms of profitability, EVH's ROE is -0.78%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, EVH is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for EVH.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
EVH vs CMAX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CMAX's P/E ratio is -0.00. In terms of profitability, EVH's ROE is -0.78%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, EVH is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
EVH vs VSEE Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas VSEE's P/E ratio is -0.19. In terms of profitability, EVH's ROE is -0.78%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, EVH is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for EVH.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
EVH vs ACON Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ACON trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ACON's P/E ratio is -0.24. In terms of profitability, EVH's ROE is -0.78%, compared to ACON's ROE of -0.54%. Regarding short-term risk, EVH is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for EVH.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
EVH vs LIFWZ Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, EVH is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for EVH.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
EVH vs EUDAW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, EVH's ROE is -0.78%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, EVH is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for EVH.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
EVH vs WORX Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas WORX's P/E ratio is -0.76. In terms of profitability, EVH's ROE is -0.78%, compared to WORX's ROE of -0.65%. Regarding short-term risk, EVH is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for EVH.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
EVH vs MSPRZ Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, EVH is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for EVH.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
EVH vs KERN Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas KERN's P/E ratio is -0.01. In terms of profitability, EVH's ROE is -0.78%, compared to KERN's ROE of -0.17%. Regarding short-term risk, EVH is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for EVH.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
EVH vs KERNW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas KERNW's P/E ratio is -0.00. In terms of profitability, EVH's ROE is -0.78%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, EVH is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for EVH.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
EVH vs LIFWW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas LIFWW's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, EVH is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for EVH.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
EVH vs ZCMD Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ZCMD trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, EVH's ROE is -0.78%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, EVH is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for EVH.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
EVH vs CMAXW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CMAXW's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, EVH is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
EVH vs ACONW Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas ACONW's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, EVH is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for EVH.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
EVH vs MTBCO Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MTBCO's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, EVH is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for EVH.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
EVH vs MSPRV Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MSPRV's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to MSPRV's ROE of N/A. Regarding short-term risk, EVH is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for EVH.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
EVH vs MTBCP Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MTBCP's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, EVH is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for EVH.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
EVH vs MTBC Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas MTBC's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, EVH is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for EVH.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
EVH vs CHNG Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CHNG's P/E ratio is -152.72. In terms of profitability, EVH's ROE is -0.78%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, EVH is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
EVH vs CHNGU Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CHNGU's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, EVH is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
EVH vs CNVY Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CNVY's P/E ratio is -71.50. In terms of profitability, EVH's ROE is -0.78%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, EVH is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
EVH vs NAVA Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas NAVA's P/E ratio is N/A. In terms of profitability, EVH's ROE is -0.78%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, EVH is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for EVH.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
EVH vs CERN Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CERN has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CERN's P/E ratio is 55.84. In terms of profitability, EVH's ROE is -0.78%, compared to CERN's ROE of +0.14%. Regarding short-term risk, EVH is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
EVH vs CSLT Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas CSLT's P/E ratio is -37.27. In terms of profitability, EVH's ROE is -0.78%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, EVH is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for EVH.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
EVH vs NH Comparison July 2026
Evolent Health, Inc. (NYSE: EVH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVH stands at 652.4M. In comparison, NH has a market cap of 0. Regarding current trading prices, EVH is priced at $5.74 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVH currently has a P/E ratio of 580.00, whereas NH's P/E ratio is -0.12. In terms of profitability, EVH's ROE is -0.78%, compared to NH's ROE of +0.35%. Regarding short-term risk, EVH is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for EVH.Check NH's competition here